Suzhou Ribo Life Science, a Chinese drug developer that focuses on liver diseases, has raised a RMB270 million ($40 million) Series B round led by SDIC Fund Management.
Other new investors include China Resources, Zhenghe Yuantong Capital and TusPark Ventures. Existing investors Legend Capital, GGV Capital and Fortune United Partners have also re-upped, according to a...
Baidu Capital, a VC firm backed by Chinese search engine Baidu, has led a round of funding for WM Motor Technology, a Chinese electric vehicle manufacturer.
NSI Ventures has reached a first close of approximately $60 million on its second Southeast Asia venture capital fund and also participated in a $5 million Series A round for Singapore-based digital healthcare company Biofourmis.
The International Finance Corporation (IFC), the investment arm of the World Bank, is considering a commitment of up to $20 million in the third India-focused vehicle of Lighthouse Funds.
GenBridge Capital, a private equity firm set up by former executives from Chinese online retailer JD.com and TPG Capital, has closed its debut consumer-focused fund at the hard cap of $500 million.